Table 3.
Survival depending to both HGP and metabolic clinical risk score
| DHGP (n = 22) | Non‐DHGP (n = 86) | p | |||
|---|---|---|---|---|---|
| Low risk mCRS (n = 17) | High risk mCRS (n = 5) | Low risk mCRS (n = 63) | High risk mCRS (n = 23) | ||
| OS | 0.007 | ||||
| 3 years | 83.3% | 17.9% | 57% | 37.9% | |
| 5 years | 83.3% | 17.9% | 34.3% | 37.9% | |
| 10 years | 62.5% | 0% | 22.8% | 14.2% | |
| Median OS | 16.6 months | 43.3 months | 25 months | ||
| DFS | 0.003 | ||||
| 3 years | 49.7% | 0% | 16.6% | 0% | |
| 5 years | 33.1% | 0% | 13.8% | 0% | |
| 10 years | |||||
| Median DFS | 72 months | 10 months | 28 months | 7.4 | |
Abbreviations: DFS, disease free survival; mCRS, metabolic clinical risk score; OS, overall survival.